NasdaqCM - Delayed Quote USD
Artelo Biosciences, Inc. (ARTL)
1.0500
+0.0400
+(3.96%)
At close: May 30 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.13 | -0.14 | -1.08 | -0.52 |
| Low Estimate | -0.13 | -0.14 | -1.08 | -0.52 |
| High Estimate | -0.13 | -0.14 | -1.08 | -0.52 |
| Year Ago EPS | -- | -0.35 | -3.05 | -1.08 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.85 | -1.78 | -0.38 | -0.13 |
| EPS Actual | -0.75 | -0.35 | -1.17 | -0.72 |
| Difference | 0.1 | 1.43 | -0.79 | -0.59 |
| Surprise % | 11.42% | 80.34% | -207.89% | -453.85% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.13 | -0.14 | -1.08 | -0.52 |
| 7 Days Ago | -0.13 | -0.14 | -1.08 | -0.52 |
| 30 Days Ago | -0.13 | -0.14 | -1.16 | -0.52 |
| 60 Days Ago | -0.13 | -0.14 | -1.16 | -0.52 |
| 90 Days Ago | -0.13 | -0.14 | -0.48 | -0.52 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ARTL | -- | 60.00% | 64.59% | 51.85% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 4/28/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 4/2/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/4/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/3/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 2/27/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 1/14/2025 |
Related Tickers
THAR Tharimmune, Inc.
1.4522
-1.21%
SLRX Salarius Pharmaceuticals, Inc.
0.7629
-3.43%
LYEL Lyell Immunopharma, Inc.
0.4367
+8.74%
BXRXQ Baudax Bio, Inc.
0.0001
+9,900.00%
AZTR Azitra, Inc.
0.2740
+1.11%
ENTO Entero Therapeutics, Inc.
0.4335
+5.22%
CMMB Chemomab Therapeutics Ltd.
1.3200
-3.65%
SNPX Synaptogenix, Inc.
2.5150
+2.24%
DYAI Dyadic International, Inc.
1.0370
+0.19%
HOOK HOOKIPA Pharma Inc.
1.5900
-1.24%